The Kidney Disease: Improving Global Outcomes (KDIGO) organization has released an updated April 2024 clinical practice guideline for the evaluation and management of Chronic Kidney Disease (CKD). The new 2024 KDIGO guidelines include 6 chapters dedicated to the...
The 2024 ADA guidelines were released a month or two ago and I wanted to take a little time to digest them before providing my big takeaways. The 2023 guidelines saw a major shift in pharmacotherapy with a strong emphasis on compelling indications and recommended...
The 2023 GOLD Guidelines were released a little while ago and I don’t think there is anything earth-shattering in medication selection. The biggest thing associated with these guidelines compared to previous editions is the fact that it encourages a little more...
Heart failure is a disease state that requires a significant number of medications. Guideline-based standards of care now include numerous medications. How did we get there? I outline my top 5 heart failure clinical trials of all time. Feel free to leave a comment if...
In this article, we lay out our top 5 all-time hypertension clinical trials. If you remember previously, we covered the top 5 landmark clinical trials in hyperlipidemia. It was a tough call with many options, but here’s our list of hypertension clinical trials....
The ADA has released its 2023 guidelines. There are a significant number of impacts on medication therapy, and in this post I will outline my most important takeaways. I was also recently catching up with my friend and fellow pharmacist, Derek Borkowski who is the...
